Nigerian Public Alert 87: The National Agency for Food and Drug Administration and Control (NAFDAC) wishes to inform healthcare professionals, distributors, wholesalers, retailers, Patent and Proprietary Medicine Vendors (PPMVs), healthcare institutions, and the general public that products marketed by Mofus Nigeria Ltd have been placed on the NAFDAC Watchlist pending the outcome of an ongoing regulatory investigation.
Category: Admin: Public Alerts
Nigerian Public Alert 86: NAFDAC Notifies on Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
Nigerian Public Alert 86: The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers, importers, distributors, retailers, Patent and Proprietary Medicine Vendors (PPMVs), and the general public of the seizure of a suspected Substandard and Falsified (SF) antimalarial medicine, Artemether/Lumefantrine 80mg/480mg, purportedly manufactured by Bandaram Pharma Packleh Ltd (BPPL), India.
Nigerian Public Alert 85: NAFDAC Notifies on Suspected Counterfeit ORACIRE+ Toothpaste
Nigerian Public Alert 85: The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the circulation of a suspected counterfeit toothpaste product, ORACIRE+ TOOTHPASTE, which is being distributed in Nigeria under the guise of the registered ORACARE+ Toothpaste.
Nigerian Public Alert 84: NAFDAC Notifies on Regulatory Clarification on Deleject Disposable Needle
Nigerian Public Alert 84: The public Alert No. 042/2026, concerning the reported presence of whitish particulate matter in Deleject Disposable Needle Batch No. 240605, was uploaded onto the NAFDAC website in error.
Nigerian Public Alert 83: NAFDAC Notifies on Suspected Counterfeit Pulmicort® (Budesonide) Inhalation Suspension
Nigerian Public Alert 83: The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the detection of a suspected counterfeit medicinal product found in the Nigerian market that infringes on the approved marketing authorization of Pulmicort® (Budesonide) manufactured by AstraZeneca. The information was provided to NAFDAC by AstraZeneca following market surveillance activities.
Nigerian Public Alert 82: NAFDAC Notifies on Suspected Counterfeit Products Mimicking Forxiga® (Dapagliflozin)
Nigerian Public Alert 82: The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the detection of suspected counterfeit medicinal products found in the Nigerian market that infringe on the approved marketing authorization of Forxiga® (dapagliflozin) manufactured by AstraZeneca.
Nigerian Public Alert 81: NAFDAC Notifies on Marketing and Sale of Unregistered Menofix Composition
Nigerian Public Alert 81: The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the marketing and sale of unregistered Menofix Composition.